<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://techtimesnewyork.com/article/914063919-tinifiber-acquires-fiber-optic-connectivity-specialist-corelinc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:15:00+00:00</news:publication_date>
        <news:title>TiniFiber Acquires Fiber Optic Connectivity Specialist CoreLinc </news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863645-tinifiber-acquires-fiber-optic-3300x1858.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914202650-2026-vega-digital-awards-season-1-winners-announced-recognizing-global-excellence-in-digital-creativity-and-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:30:00+00:00</news:publication_date>
        <news:title>2026 Vega Digital Awards Season 1 Winners Announced — Recognizing Global Excellence in Digital Creativity and Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864142-2026-vega-digital-awards-s1-ful-1920x950.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914305034-coping-transforming-adversity-into-meaning-and-purpose</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:16:55+00:00</news:publication_date>
        <news:title>Coping: Transforming Adversity into Meaning and Purpose</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864454-coping-how-we-choose-to-respon-2779x1854.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914083046-advance-funds-network-ranked-1-best-in-non-bank-financial-service-in-the-united-states-on-trustpilot</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:00:00+00:00</news:publication_date>
        <news:title>Advance Funds Network Ranked #1 Best in Non-Bank Financial Service in the United States on Trustpilot</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863933-advance-funds-network-rated-1-1344x894.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914393041-ibrx-4-day-deadline-alert-immunitybio-ibrx-investors-face-losses-amid-fda-warning-regarding-unsupported-cancer-treatment-claims-hagens-berman</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:48:55+00:00</news:publication_date>
        <news:title>IBRX 4-DAY DEADLINE ALERT: ImmunityBio (IBRX) Investors Face Losses Amid FDA Warning Regarding Unsupported Cancer Treatment Claims – Hagens Berman</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b600e36f-b3e3-496b-a7b8-97e9409ab427/medium/immunitybio-inc-ibrx-securities-class-action.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914392916-vs-media-enters-the-ai-smart-living-sector-to-explore-new-growth-opportunities</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:47:00+00:00</news:publication_date>
        <news:title>VS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3967408f-380c-4235-a4eb-36829439e2a8/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914392899-deadline-alert-for-srad-cvlt-and-veri-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-actions-on-behalf-of-shareholders</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:43:16+00:00</news:publication_date>
        <news:title>DEADLINE ALERT for SRAD, CVLT, and VERI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/778ea178-25d1-48a3-9141-a162814899d4/small/close-up-logo-hd-blue-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914392847-deadline-alert-for-stla-uhg-lkq-glob-law-offices-of-howard-g-smith-reminds-investors-of-opportunity-to-lead-securities-fraud-class-actions</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:39:44+00:00</news:publication_date>
        <news:title>DEADLINE ALERT for STLA, UHG, LKQ, GLOB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ODI0NjBmY2QtMGE1My00NjQ2LWE3Y2EtZTlkOWI3YzM4ODFjLTEwMzIyOTktMjAyNi0wNS0yMi1lbg==/tiny/Law-Offices-of-Howard-G-Smith.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914392852-sportradar-group-ag-srad-securities-class-action-filed-amid-activist-short-seller-accusations-of-illegal-business-model-and-800-million-market-cap</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:35:20+00:00</news:publication_date>
        <news:title>Sportradar Group AG (SRAD) Securities Class Action Filed Amid Activist Short Seller Accusations of Illegal Business Model and $800 Million Market Cap Wipeout – Hagens Berman</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43/small/11-25-2025-hbss-securities-unbold-space-1-0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914058126-prepare-for-job-loss-during-the-fourth-industrial-revolution-of-ai-says-industry-analyst-jeff-kagan</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T04:15:00+00:00</news:publication_date>
        <news:title>Prepare for Job Loss During the Fourth Industrial Revolution of AI, says Industry Analyst Jeff Kagan</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24591747-jeff-kagan-industry-analyst-565x881.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914383810-bronstein-gewirtz-grossman-llc-urges-medpace-holdings-inc-investors-to-act-class-action-filed-alleging-investor-harm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:00:00+00:00</news:publication_date>
        <news:title>Bronstein, Gewirtz &amp; Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914383859-bronstein-gewirtz-grossman-llc-urges-lkq-corporation-investors-to-act-class-action-filed-alleging-investor-harm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:00:00+00:00</news:publication_date>
        <news:title>Bronstein, Gewirtz &amp; Grossman LLC Urges LKQ Corporation Investors to Act: Class Action Filed Alleging Investor Harm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914383965-bronstein-gewirtz-grossman-llc-urges-super-micro-computer-inc-investors-to-act-class-action-filed-alleging-investor-harm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:00:00+00:00</news:publication_date>
        <news:title>Bronstein, Gewirtz &amp; Grossman LLC Urges Super Micro Computer, Inc. Investors to Act: Class Action Filed Alleging Investor Harm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914384063-bronstein-gewirtz-grossman-llc-urges-sportradar-group-ag-investors-to-act-class-action-filed-alleging-investor-harm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T16:00:00+00:00</news:publication_date>
        <news:title>Bronstein, Gewirtz &amp; Grossman LLC Urges Sportradar Group AG Investors to Act: Class Action Filed Alleging Investor Harm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a031130-a9cc-48ff-b281-d1e47c9a91a5/small/bronstein-gewirtz-grossman-llc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914384332-manh-investor-news-rosen-law-firm-announces-investigation-of-breaches-of-fiduciary-duties-by-the-directors-and-officers-of-manhattan-associates-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T15:46:23+00:00</news:publication_date>
        <news:title>MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914384305-commvault-systems-cvlt-securities-class-action-filed-amid-q3-2026-s-apparent-inconsistencies-with-prior-growth-narrative-and-1-7b-market-cap</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T15:44:59+00:00</news:publication_date>
        <news:title>Commvault Systems (CVLT) Securities Class Action Filed Amid Q3 2026’s Apparent Inconsistencies With Prior Growth Narrative and $1.7B Market Cap Wipeout – Hagens Berman</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43/small/11-25-2025-hbss-securities-unbold-space-1-0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914375548-the-newest-name-on-nasdaq-wants-to-help-the-body-rebuild-itself</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T15:30:00+00:00</news:publication_date>
        <news:title>The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/537a8428-aa51-425e-b0c7-625da6b05a49/small/95686-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914375669-asus-rog-zephyrus-g14-and-g16-arrive-in-the-us-with-intel-core-ultra-series-3-and-rtx-50-series</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T15:30:00+00:00</news:publication_date>
        <news:title>ASUS ROG Zephyrus G14 and G16 Arrive in the US with Intel Core Ultra Series 3 and RTX 50 Series</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/66516e31-9125-471a-9e1a-c79ac29a1e8c/small/asus-logo-icon-247542-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914375793-portnoy-law-firm-announces-class-action-on-behalf-of-commvault-systems-inc-investors</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T15:11:57+00:00</news:publication_date>
        <news:title>Portnoy Law Firm Announces Class Action on Behalf of Commvault Systems, Inc. Investors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ea0dd9c0-6e41-4d5a-ad27-b277677af6df/small/portnoylaw-logohighresroundlogoonly-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914375658-portnoy-law-firm-announces-class-action-on-behalf-of-sportradar-group-ag-investors</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T15:07:34+00:00</news:publication_date>
        <news:title>Portnoy Law Firm Announces Class Action on Behalf of Sportradar Group AG Investors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ea0dd9c0-6e41-4d5a-ad27-b277677af6df/small/portnoylaw-logohighresroundlogoonly-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914375626-portnoy-law-firm-announces-class-action-on-behalf-of-championx-corporation-investors</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T15:05:31+00:00</news:publication_date>
        <news:title>Portnoy Law Firm Announces Class Action on Behalf of ChampionX Corporation Investors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ea0dd9c0-6e41-4d5a-ad27-b277677af6df/small/portnoylaw-logohighresroundlogoonly-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367662-cuprina-holdings-announces-1-for-8-share-consolidation</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:50:00+00:00</news:publication_date>
        <news:title>Cuprina Holdings announces 1-for-8 Share Consolidation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/951432c6-1aa2-46d5-a0e6-10e9ca7ca73a/small/cuprina-holdings-long-logo-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367936-sophos-named-a-champion-in-omdia-cybersecurity-msp-ecosystems-leadership-matrix-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:46:25+00:00</news:publication_date>
        <news:title>Sophos Named a Champion in Omdia Cybersecurity MSP Ecosystems Leadership Matrix 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7a7cb431-cd32-404d-bdc0-6f6ea4fbcaf2/medium/omdia-cybersecurity-msp-ecosystems-leadership-matrix-2026.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367919-poet-technologies-inc-investors-have-until-june-29th-to-contact-bragar-eagel-squire-p-c-to-seek-lead-plaintiff-role</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:38:03+00:00</news:publication_date>
        <news:title>POET Technologies, Inc. Investors Have Until June 29th to Contact Bragar Eagel &amp; Squire, P.C. To Seek Lead Plaintiff Role</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367889-atra-deadline-today-rosen-a-leading-law-firm-encourages-atara-biotherapeutics-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:32:42+00:00</news:publication_date>
        <news:title>ATRA DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Atara Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 22 Deadline in Securities Class Action - ATRA</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367827-poet-investors-have-opportunity-to-lead-poet-technologies-inc-securities-fraud-lawsuit-with-the-schall-law-firm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:29:16+00:00</news:publication_date>
        <news:title>POET Investors Have Opportunity to Lead POET Technologies Inc. Securities Fraud Lawsuit with the Schall Law Firm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/60f84371-8ef5-454a-ab60-63e56a837741/small/schall-firm-logo-2-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367817-intuit-inc-shareholders-are-encouraged-to-reach-out-to-johnson-fistel-for-more-information-about-potentially-recovering-their-losses</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:29:10+00:00</news:publication_date>
        <news:title>Intuit Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c/small/johnson-fistel-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367816-semilux-international-ltd-announces-receipt-of-nasdaq-staff-determination-letter-and-intention-to-request-hearing</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:28:26+00:00</news:publication_date>
        <news:title>SemiLux International Ltd. Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZTc5OGQ2NmQtNDIwMS00NGUyLTk5ZWUtOTliYmQ0ZTg3ZWI4LTUwMDEyNDc0NC0yMDI2LTA1LTIyLWVu/tiny/Semilux-International-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367706-upst-investors-have-opportunity-to-lead-upstart-holdings-inc-securities-fraud-lawsuit-with-the-schall-law-firm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:21:20+00:00</news:publication_date>
        <news:title>UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/60f84371-8ef5-454a-ab60-63e56a837741/small/schall-firm-logo-2-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367691-medp-investors-have-opportunity-to-lead-medpace-holdings-inc-securities-fraud-lawsuit-with-the-schall-law-firm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:16:35+00:00</news:publication_date>
        <news:title>MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/60f84371-8ef5-454a-ab60-63e56a837741/small/schall-firm-logo-2-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914367686-ktc-expands-mini-led-monitor-lineup-as-technology-moves-toward-mainstream-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:13:49+00:00</news:publication_date>
        <news:title>KTC Expands Mini-LED Monitor Lineup as Technology Moves Toward Mainstream Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e189dbb5-8ec9-44e9-911d-f7dc138def79/small/ktc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359363-ai-r-lan-a-plataforma-para-dar-visibilidade-aos-gastos-com-intelig-ncia-artificial-nas-organiza-es</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:09:56+00:00</news:publication_date>
        <news:title>AI/R lança plataforma para dar visibilidade aos gastos com inteligência artificial nas organizações</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZWM2OTg5ZDctOTRkNC00MDI3LWIwOGEtMTk1MmE0OWM3YjVjLTEzMTQ0MDgtMjAyNi0wNS0yMi1wdA==/tiny/AI-R-Group-US-Holding-Corp.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359350-a-reno-biotech-just-rang-the-nasdaq-bell-here-s-why-the-whole-regenerative-medicine-tape-is-worth-watching</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:09:44+00:00</news:publication_date>
        <news:title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/186a6ff0-f562-4d97-afcc-6aa99ce6be51/small/screenshot-20260422-104629-chrome-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359060-award-winning-hr-software-vendor-hibob-named-an-isg-2026-vendor-of-excellence-for-human-resources-management-system-hrms</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:00:00+00:00</news:publication_date>
        <news:title>Award-winning HR Software Vendor HiBob Named an ISG 2026 Vendor of Excellence for Human Resources Management System (HRMS)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3211519/https___research.isg-one.com_hubfs_buyers_guide_badges_ISG_Exemplary_HRMS_2026.png.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359119-hibob-named-best-hr-management-software-in-the-uk-for-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:00:00+00:00</news:publication_date>
        <news:title>HiBob Named Best HR Management Software in the UK for 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3234489/SCR-20260316-kxfp.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359138-investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-wix-com-ltd-wix</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:00:00+00:00</news:publication_date>
        <news:title>INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Wix.com Ltd. - WIX</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZjliODI1MzUtMWVjMC00ZjM3LWI0YTAtZDYyNWNjNzc0NWI5LTEwMjkyMTctMjAyNi0wNS0yMi1lbg==/tiny/Pomerantz-LLP.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359187-zawa-upgrades-ai-logo-generator-with-smarter-design-modes-for-small-businesses-and-creators</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T14:00:00+00:00</news:publication_date>
        <news:title>Zawa Upgrades AI Logo Generator with Smarter Design Modes for Small Businesses and Creators</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cc128e79-6f05-429b-b51c-c072004c8e30/medium/zawa-ai-branding-design.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359312-this-emerging-biotech-wave-could-create-the-next-monster-healthcare-winners</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:42:40+00:00</news:publication_date>
        <news:title>This Emerging Biotech Wave Could Create the Next Monster Healthcare Winners</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2YwYjhmMGItMjI2NC00MTgyLWI0Y2UtOTE5ZmE2NzEyMDk2LTEzMTU5MTMtMjAyNi0wNS0yMi1lbg==/tiny/24-7-Market-News.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914359304-xmax-announces-additional-ai-services-agreement-expected-to-generate-up-to-approximately-3-6-million-in-annual-revenue</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:41:55+00:00</news:publication_date>
        <news:title>XMax Announces Additional AI Services Agreement Expected to Generate Up to Approximately $3.6 Million in Annual Revenue</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e10d1bfc-a129-4ecb-a8d1-7a1d339f22eb/small/xmax-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350225-johnson-fistel-investigates-potential-board-fiduciary-duty-breaches-at-kelly-services-inc-following-controlling-stockholder-s-request-for-special</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:26:42+00:00</news:publication_date>
        <news:title>Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches at Kelly Services, Inc. Following Controlling Stockholder’s Request for Special Committee</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c/small/johnson-fistel-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350214-micron-advances-made-in-america-memory-with-manufacturing-expansion-in-virginia</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:25:00+00:00</news:publication_date>
        <news:title>Micron Advances Made-in-America Memory With Manufacturing Expansion in Virginia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7b41b567-5fa9-4dee-8bcb-9ea728ca57ee/small/micron-logo-black-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350024-imperial-petroleum-inc-reports-q1-26-results-second-best-quarterly-results-in-its-history</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:20:00+00:00</news:publication_date>
        <news:title>IMPERIAL PETROLEUM INC. Reports Q1 26 results, SECOND BEST QUARTERLY results in its history</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/3595ff2a-08ee-43a6-972c-031161de23b9/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350177-agios-pyrukynd-mitapivat-approved-in-the-european-union-for-adults-with-thalassemia</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:15:00+00:00</news:publication_date>
        <news:title>Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350118-oncolytics-biotech-to-present-data-at-asco-2026-reinforcing-pelareorep-s-potential-across-gastrointestinal-tumors</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:00:00+00:00</news:publication_date>
        <news:title>Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350127-bioage-labs-to-present-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:00:00+00:00</news:publication_date>
        <news:title>BioAge Labs to Present at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350149-major-announcement-us-4-0-billion-valuation-and-a-us-10-00-per-share-reference-price-agae-to-issue-shares-to-acquire-hyalroute-a-scarce-southeast</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:00:00+00:00</news:publication_date>
        <news:title>Major Announcement: US$4.0 Billion Valuation and a US$10.00 Per Share Reference Price, AGAE to Issue Shares to Acquire HyalRoute, a Scarce Southeast Asian Fiber-Optic Infrastructure Leader, Transforming into a Global AI Optical Network Platform…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YmIwODQyYzQtYzE0OC00OTY2LTk4M2QtNWRkOTM2NDI2MmJmLTEzMjA4NzYtMjAyNi0wNS0yMi1lbg==/tiny/Allied-Gaming-Entertainment.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350163-40-10-agae-hyralroute-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:00:00+00:00</news:publication_date>
        <news:title>重磅新闻：估值40亿美元、定价10美元/股，AGAE增发股份收购东南亚稀缺光纤巨头HyralRoute，转型为“光算力+光传输”全球AI光网</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YmIwODQyYzQtYzE0OC00OTY2LTk4M2QtNWRkOTM2NDI2MmJmLTEzMjA4NzYtMjAyNi0wNS0yMi16aC1IYW5z/tiny/Allied-Gaming-Entertainment.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914350172-global-mofy-ai-limited-announces-pricing-of-8-million-registered-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T13:00:00+00:00</news:publication_date>
        <news:title>Global Mofy AI Limited Announces Pricing of $8 Million Registered Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/56c95e15-3b27-4e17-b224-b8ae6f63557a/small/20240205142228-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341721-important-notice-to-long-term-shareholders-of-lkq-corporation-nasdaq-lkq-mongodb-inc-nasdaq-mdb-new-era-energy-digital-inc-nasdaq</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:31:30+00:00</news:publication_date>
        <news:title>Important Notice to Long-Term Shareholders of LKQ Corporation (NASDAQ: LKQ); MongoDB, Inc. (NASDAQ: MDB); New Era Energy &amp; Digital, Inc. (NASDAQ: NUAI); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6c801a52-ae63-4c0d-a62c-5713903ad05d/small/grabar-law-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341259-20-20-biolabs-commences-emergency-planning-for-ebola-hantavirus-lab-testing-if-outbreak-creates-overflow-demand</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:31:00+00:00</news:publication_date>
        <news:title>20/20 Biolabs Commences Emergency Planning for Ebola &amp; Hantavirus Lab Testing if Outbreak Creates Overflow Demand</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341197-evolution-metals-technologies-corp-reports-first-quarter-2026-financial-results-and-provides-corporate-update</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>Evolution Metals &amp; Technologies Corp. Reports First Quarter 2026 Financial Results and Provides Corporate Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/4dfed5d6-06df-441b-9452-36217ac602d6/small/emat-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341214-fibrobiologics-presents-preclinical-data-demonstrating-durable-immunomodulation-in-psoriasis-at-the-society-for-investigative-dermatology-2026-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341249-netcapital-schedules-business-update-conference-call-for-may-28-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>Netcapital Schedules Business Update Conference Call for May 28, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5380deaa-47b8-4805-8ada-9528988af995/small/netcapital-inc-logo-full-color-5-1-1-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341294-ebola-outbreak-spreading-at-alarming-speed-who-warns-growing-global-health-emergencies-highlight-rising-need-for-tomi-s-steramist-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>Ebola Outbreak “Spreading at Alarming Speed,” WHO Warns — Growing Global Health Emergencies Highlight Rising Need for TOMI’s SteraMist Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341319-snail-games-highlights-progress-and-development-from-strategic-polish-studio-partnerships</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>Snail Games Highlights Progress and Development from Strategic Polish Studio Partnerships</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/be395172-b461-4e27-85f8-f4ab11cd12eb/small/snail-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341459-ark-plan-renamed-to-binance-plan-baiya-international-group-inc-establishes-1-million-strategic-bnb-position</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>&quot;Ark Plan&quot; Renamed to &quot;Binance Plan&quot;: Baiya International Group Inc. Establishes $1 Million Strategic BNB Position</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/db69e6e9-efb7-4995-ad08-982098b7687a/small/logo-edited-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341487-cycurion-acquires-secuvant-supercharging-ai-driven-cybersecurity-with-automated-scalable-threat-defense-perfectly-complements-havenx-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>Cycurion Acquires Secuvant, Supercharging AI-Driven Cybersecurity with Automated, Scalable Threat Defense – Perfectly Complements HavenX Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2I3Nzg2N2QtYTBkMi00YTg2LWIzZGYtZDQxNmMwZjViMTM1LTEzMTA0NTAtMjAyNi0wNS0yMi1lbg==/tiny/Cycurion.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341582-global-mofy-announces-milestone-for-gausspeed-ai-platform-developed-in-conjunction-with-nvidia-omniverse-connects-with-digital-asset-libraries</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:30:00+00:00</news:publication_date>
        <news:title>Global Mofy Announces Milestone for Gausspeed: AI Platform Developed in Conjunction with NVIDIA Omniverse Connects with Digital Asset Libraries</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/56c95e15-3b27-4e17-b224-b8ae6f63557a/small/20240205142228-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341229-chmp-issues-positive-opinion-for-jascayd-nerandomilast-bringing-a-new-ipf-and-ppf-therapy-closer-to-patients-in-the-eu</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:15:00+00:00</news:publication_date>
        <news:title>CHMP issues positive opinion for JASCAYD® (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914341489-shimmick-corporation-prices-underwritten-public-offering-of-common-stock</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:15:00+00:00</news:publication_date>
        <news:title>Shimmick Corporation Prices Underwritten Public Offering of Common Stock</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NmQwMDIzNTUtOWY0OC00ODAxLTg5ODEtYWY0YTZiYzQ5NDAwLTEwMzc0MDYtMjAyNi0wNS0yMi1lbg==/tiny/Shimmick-Corporation.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331655-cleantech-reps-gets-23-6m-to-turn-road-traffic-into-clean-electricity-at-scale</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>Cleantech REPS gets $23.6M to turn road traffic into clean electricity at scale</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/3f50fc70-f795-4605-b010-3140cd7fd46a/small/reps-logo-transparent-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331661-black-diamond-therapeutics-to-participate-in-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331685-phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331686-anavex-life-sciences-receives-expected-nasdaq-delinquency-notification</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331725-sunpower-adds-5m-to-recent-41m-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>SunPower Adds $5M to Recent $41M Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/46eed9d8-3d8e-4674-afcd-118d36b8fb67/small/sunpower-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331726-bitfufu-to-report-first-quarter-2026-unaudited-financial-results-on-may-29-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>BitFuFu to Report First Quarter 2026 Unaudited Financial Results on May 29, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e8d293ab-eab6-48dd-8a32-f388c05d1cef/small/1200x628-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331779-wrap-developing-directional-light-scenarios-and-non-lethal-response-nlr-technologies-for-wrapreality-vr-training-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>WRAP® Developing Directional Light Scenarios and Non-Lethal Response (NLR) Technologies for WrapReality® VR Training Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4bb925f9-68c4-4202-b586-7437078944f3/small/yahoo-finance-wrap-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331792-2026-asco-pivotal-data-of-innocare-s-novel-bcl2-inhibitor-mesutoclax-released</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T12:00:00+00:00</news:publication_date>
        <news:title>2026 ASCO | Pivotal Data of InnoCare&#39;s Novel BCL2 Inhibitor Mesutoclax Released</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331680-briacell-presentations-highlight-positive-clinical-data-for-bria-imt-at-asco-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:30:00+00:00</news:publication_date>
        <news:title>BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914331684-repligen-corporation-to-present-at-william-blair-46th-annual-growth-stock-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:30:00+00:00</news:publication_date>
        <news:title>Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914322031-assembly-biosciences-announces-pricing-of-100-million-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:05:00+00:00</news:publication_date>
        <news:title>Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321207-ac-immune-presents-new-phase-1-data-indicating-higher-uptake-of-tdp-43-pet-tracer-aci-19626-in-patients-with-als</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321585-cartigenix-hp-backed-by-three-human-studies-as-clinicians-seek-evidence-based-joint-health-options</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>Cartigenix HP® Backed by Three Human Studies as Clinicians Seek Evidence-Based Joint Health Options</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d7dc39f8-a2af-4bdc-8746-60a8c4c3ddc8/small/calroy-health-sciences-logo-rachel-rowley-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321642-otarmeni-lunsotogene-parvec-receives-ema-filing-acceptance-for-genetic-hearing-loss</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321796-assembly-biosciences-announces-expansion-of-abi-6250-clinical-development-into-cholestatic-liver-diseases</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321880-american-shared-hospital-services-announces-annual-shareholder-meeting-to-be-held-on-june-24-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on June 24, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/87b89aa7-3561-4d88-859e-134a1465713f/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321886-medicenna-announces-the-filing-of-its-prospectus-supplement-and-investment-term-sheet</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321930-chagee-to-announce-first-quarter-2026-financial-results-on-may-28-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>Chagee to Announce First Quarter 2026 Financial Results on May 28, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZTIyMjMzOTktMTIwYS00NDkxLTllNzEtOWNjZThkNmYxMTNmLTEzMDM1NTEtMjAyNi0wNS0yMi1lbg==/tiny/Chagee-Holdings-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321939-synack-highlights-human-ai-continuous-security-validation-at-the-gartner-security-risk-management-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>Synack Highlights Human + AI Continuous Security Validation at the Gartner Security &amp; Risk Management Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a4d297b6-ecea-49ac-aa47-4bba71fd233f/small/synack-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914322018-concorde-international-group-proprietary-security-model-featured-on-world-fm-day-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T11:00:00+00:00</news:publication_date>
        <news:title>Concorde International Group Proprietary Security Model Featured on World FM Day 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/500569ea-5c4f-4620-bdb9-1f6b175aa0a8/small/concorde-international-group-ltd.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321869-arch-biopartners-announces-royal-columbian-hospital-has-dosed-its-first-patient-in-its-phase-ii-cardiac-surgery-associated-aki-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:50:00+00:00</news:publication_date>
        <news:title>Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8fae7e83-0899-4bbc-ba40-0250cdb9aea7/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321356-cvlt-lawsuit-alert-commvault-investors-are-notified-of-the-ongoing-securities-class-action-over-the-company-s-potential-misstatements-contact-bfa</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:47:00+00:00</news:publication_date>
        <news:title>$CVLT Lawsuit Alert: Commvault Investors are Notified of the Ongoing Securities Class Action Over the Company’s Potential Misstatements – Contact BFA Law if You Lost Money</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44a256cf-d470-4d8a-af6b-dbb1b5bbb11e/small/bfa-logo-transparent-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321412-medp-lawsuit-alert-medpace-investors-are-notified-of-the-ongoing-securities-class-action-over-the-company-s-potential-misstatements-contact-bfa-law</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:47:00+00:00</news:publication_date>
        <news:title>MEDP Lawsuit Alert: Medpace Investors are Notified of the Ongoing Securities Class Action Over the Company’s Potential Misstatements – Contact BFA Law if You Lost Money</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44a256cf-d470-4d8a-af6b-dbb1b5bbb11e/small/bfa-logo-transparent-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321461-srad-lawsuit-alert-sportradar-investors-are-notified-of-the-ongoing-securities-class-action-over-the-company-s-potential-misstatements-contact-bfa</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:47:00+00:00</news:publication_date>
        <news:title>SRAD Lawsuit Alert: Sportradar Investors are Notified of the Ongoing Securities Class Action Over the Company’s Potential Misstatements – Contact BFA Law if You Lost Money</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44a256cf-d470-4d8a-af6b-dbb1b5bbb11e/small/bfa-logo-transparent-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321548-wix-inquiry-news-wix-investors-are-notified-of-bfa-law-s-ongoing-investigation-into-the-company-s-potential-misstatements-contact-the-firm-if-you</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:47:00+00:00</news:publication_date>
        <news:title>WIX Inquiry News: Wix Investors are Notified of BFA Law’s Ongoing Investigation into the Company’s Potential Misstatements – Contact the Firm if You Lost Money</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44a256cf-d470-4d8a-af6b-dbb1b5bbb11e/small/bfa-logo-transparent-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321342-hubg-inquiry-news-hub-group-investors-are-notified-of-bfa-law-s-ongoing-investigation-into-the-company-s-potential-misstatements-contact-the-firm</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:46:00+00:00</news:publication_date>
        <news:title>HUBG Inquiry News: Hub Group Investors are Notified of BFA Law’s Ongoing Investigation into the Company’s Potential Misstatements – Contact the Firm if You Lost Money</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44a256cf-d470-4d8a-af6b-dbb1b5bbb11e/small/bfa-logo-transparent-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321454-smpl-inquiry-news-simply-good-foods-investors-are-notified-of-bfa-law-s-ongoing-investigation-into-the-company-s-potential-misstatements-contact</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:46:00+00:00</news:publication_date>
        <news:title>SMPL Inquiry News: Simply Good Foods Investors are Notified of BFA Law’s Ongoing Investigation into the Company’s Potential Misstatements – Contact the Firm if You Lost Money</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44a256cf-d470-4d8a-af6b-dbb1b5bbb11e/small/bfa-logo-transparent-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914322028-mission-success-rocket-lab-completes-9th-electron-launch-for-synspective</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:40:29+00:00</news:publication_date>
        <news:title>Mission Success: Rocket Lab Completes 9th Electron Launch for Synspective</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d5785cc8-1501-4a8f-8c5c-ca3e966db143/small/rocket-lab-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914321932-ftai-aviation-prices-inaugural-asset-backed-securitization</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:30:00+00:00</news:publication_date>
        <news:title>FTAI Aviation Prices Inaugural Asset-Backed Securitization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1175954b-a2cb-4f90-840b-87999d0ba290/small/ftai-aviation-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914309224-tuesday-investor-deadline-immunitybio-inc-ibrx-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:05:00+00:00</news:publication_date>
        <news:title>TUESDAY INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a2879a30-a9fa-457e-97f6-7e2cd2528b7b/small/rgrd-logo-2-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914309222-titan-provides-update-on-management-changes</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T10:00:00+00:00</news:publication_date>
        <news:title>Titan Provides Update on Management Changes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/aa21218a-f0e4-4fe8-91f3-f92bacda93cb/small/titan-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914309275-wemade-gears-up-for-2nd-global-esports-tournament-ymir-cup-world-championship</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T09:57:14+00:00</news:publication_date>
        <news:title>WEMADE Gears Up for 2nd Global Esports Tournament, YMIR Cup World Championship</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ff520552-3c76-44fb-b02a-e86962a1acb1/medium/ymir-cup-world-championship-season-2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914295860-biontech-pr-sentiert-auf-der-asco-jahrestagung-2026-fortschritte-aus-pipelineprogrammen-in-der-sp-ten-klinischen-entwicklung</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T09:00:00+00:00</news:publication_date>
        <news:title>BioNTech präsentiert auf der ASCO-Jahrestagung 2026 Fortschritte aus Pipelineprogrammen in der späten klinischen Entwicklung</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914295902-biontech-to-showcase-progress-across-late-stage-oncology-pipeline-at-the-2026-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T09:00:00+00:00</news:publication_date>
        <news:title>BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914280790-fushi-tech-launches-general-purpose-ai-agent-for-overseas-merchants</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T07:50:27+00:00</news:publication_date>
        <news:title>Fushi Tech Launches General-Purpose AI Agent for Overseas Merchants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDRkZmFlMGMtMTIyNy00ZDZhLTk5ZTMtYTEwODQ0NTRmZjNmLTUwMDE1NjM0My0yMDI2LTA1LTIyLWVu/tiny/Shenzhen-Fushi-Technology-Co-L.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914280832</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T07:50:27+00:00</news:publication_date>
        <news:title>富匙科技發佈新品 為海外商戶提供通用數字員工</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDRkZmFlMGMtMTIyNy00ZDZhLTk5ZTMtYTEwODQ0NTRmZjNmLTUwMDE1NjM0My0yMDI2LTA1LTIyLXpoLUhhbnQ=/tiny/Shenzhen-Fushi-Technology-Co-L.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914280549-china-approves-hernexeos-as-first-targeted-oral-treatment-option-for-her2-mutant-advanced-nsclc-at-initial-diagnosis</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T07:45:00+00:00</news:publication_date>
        <news:title>China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914280532-storm-therapeutics-to-present-promising-phase-1-sarcoma-data-demonstrating-activity-of-first-in-class-mettl3-inhibitor-stc-15-at-asco-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T07:30:00+00:00</news:publication_date>
        <news:title>STORM Therapeutics to Present Promising Phase 1 Sarcoma Data Demonstrating Activity of First‑in‑Class METTL3 Inhibitor STC‑15 at ASCO 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/1f159389-0c23-4305-b40e-b83e89274cee/small/logo-png.PNG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914264242-smci-super-micro-computer-inc-100</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T06:25:36+00:00</news:publication_date>
        <news:title>מועד אחרון לתביעה ייצוגית נגד SMCI: רוזן, יועץ למשקיעים מהימן, מעודד את משקיעי Super Micro Computer, Inc עם הפסדים של יותר מ-100 אלף דולר לקבל ייעוץ לפני המועד האחרון החשוב ב-26 במאי בתביעה ייצוגית לניירות ערך - SMC…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914264116-hanmi-pharmaceutical-se-asocia-con-organon-para-exportar-terapias-combinadas-al-sudeste-asi-tico</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T06:20:18+00:00</news:publication_date>
        <news:title>Hanmi Pharmaceutical se asocia con Organon para exportar terapias combinadas al Sudeste Asiático</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/526a18fe-e048-4862-91e5-0a6effeaf8ab/small/hanmi-pharmaceutical-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914264215-hanmi-pharmaceutical-faz-parceria-com-a-organon-para-exporta-o-de-terapias-de-combina-o-para-o-sudeste-asi-tico</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T06:20:18+00:00</news:publication_date>
        <news:title>Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/526a18fe-e048-4862-91e5-0a6effeaf8ab/small/hanmi-pharmaceutical-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914264099-gossamer-gossamer-bio-inc-100</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T06:14:08+00:00</news:publication_date>
        <news:title>הודעת מועד אחרון לתביעה ייצוגית נגד GOSSAMER: רוזן, יועץ למשקיעים מוביל, מעודד משקיעים ב- Gossamer Bio, Inc. עם הפסדים של יותר מ-100 אלף דולר לקבל ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית לניירות ערך – GOS…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914264043-angel-introduces-x2-water-filter-system-with-advanced-tankless-7-stage-filtration-and-99-pfas-reduction</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T05:45:33+00:00</news:publication_date>
        <news:title>ANGEL Introduces X2 Water Filter System with Advanced Tankless 7-Stage Filtration and 99% PFAS Reduction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/38ebd348-2161-4e2e-bd81-b7e8c6fd5324/medium/image-1.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914263955-ose-immunotherapeutics-annonce-les-r-sultats-de-topline-positifs-de-l-tude-de-phase-2-tedova-de-tedopi-dans-le-cancer-de-l-ovaire-en-rechute</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T05:30:00+00:00</news:publication_date>
        <news:title>OSE Immunotherapeutics annonce les résultats de Topline positifs de l&#39;étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire en rechute</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914263967-ose-immunotherapeutics-reports-positive-topline-results-of-tedova-phase-2-trial-with-tedopi-in-recurrent-ovarian-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T05:30:00+00:00</news:publication_date>
        <news:title>OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914263980-bull-liefert-finnlands-neuen-nationalen-supercomputer-roihu</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T05:30:00+00:00</news:publication_date>
        <news:title>Bull liefert Finnlands neuen nationalen Supercomputer „Roihu“</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/MzMzNTE4ODQtYjgxOC00YzE5LWE4MTAtY2M4ZTZhNGMzNWMzLTEwMTEwNjktMjAyNi0wNS0yMi1kZQ==/tiny/BULL-SAS.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914263983-bull-delivers-roihu-finland-s-new-national-supercomputer</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T05:30:00+00:00</news:publication_date>
        <news:title>Bull delivers Roihu, Finland’s new national supercomputer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/MzMzNTE4ODQtYjgxOC00YzE5LWE4MTAtY2M4ZTZhNGMzNWMzLTEwMTEwNjktMjAyNi0wNS0yMi1lbg==/tiny/BULL-SAS.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914242935-nervgen-announces-pricing-of-us-60-0-million-public-offering-of-securities</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T03:27:00+00:00</news:publication_date>
        <news:title>NervGen Announces Pricing of US$60.0 Million Public Offering of Securities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914064464-espretto-secures-u-s-partnerships-across-hawaii-florida-and-new-york-as-it-advances-silicon-valley-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T15:23:05+00:00</news:publication_date>
        <news:title>Espretto Secures U.S. Partnerships Across Hawaii, Florida and New York as It Advances Silicon Valley Expansion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863646-jsdfoidfueo-915x577.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914218852-medline-inc-announces-pricing-of-upsized-secondary-offering-of-class-a-common-stock</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T02:45:00+00:00</news:publication_date>
        <news:title>Medline Inc. announces pricing of upsized secondary offering of Class A common stock</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914218694-aifa-provides-update-on-nasdaq-notice-and-filing-of-annual-report-clearing-key-pathways-for-strategic-transformation</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T02:30:00+00:00</news:publication_date>
        <news:title>AIFA Provides Update on Nasdaq Notice and Filing of Annual Report, Clearing Key Pathways for Strategic Transformation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZDNlMzYyNjItN2JkZi00YzcyLWEyZTUtNDgzYWQ1YWFiMjRkLTEzMjA4NzYtMjAyNi0wNS0yMi1lbg==/tiny/Allied-Gaming-Entertainment.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/913937295-altaclaro-expands-deposim-its-ai-powered-deposition-simulation-platform-to-include-employment-law</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T14:00:00+00:00</news:publication_date>
        <news:title>AltaClaro Expands DepoSim, its AI-powered Deposition Simulation Platform, to Include Employment Law</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/21516446-altaclaro-logo-4096x4096.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914218405-crypto-news-alphapepe-presale-q2-pancakeswap-listing-nears-as-bitcoin-price-prediction-targets-200-000</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T02:00:00+00:00</news:publication_date>
        <news:title>Crypto News: AlphaPepe Presale Q2 PancakeSwap Listing Nears as Bitcoin Price Prediction Targets $200,000</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c2b99151-5358-4d6b-ba41-f50646074d6a/medium/alphapepe-presale.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/913968893-airdroid-parental-control-earns-kidsafe-recognition-and-family-choice-award</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T13:30:00+00:00</news:publication_date>
        <news:title>AirDroid Parental Control Earns kidSAFE Recognition and Family Choice Award</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863017-kidsafe-listed-seal-01-1687x910.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914218610-fushi-tech-unveils-ai-agent-strategy-targeting-overseas-merchants</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T01:28:38+00:00</news:publication_date>
        <news:title>Fushi Tech Unveils AI Agent Strategy Targeting Overseas Merchants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWFjNzVlYTMtMTBkYS00ZTQ0LTg5ZjgtMDg5ZmUzZmY2ZGEzLTUwMDE2MzA2Ny0yMDI2LTA1LTIyLWVu/tiny/Fushi-Technology-Singapore-Pte.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/913663603-pharos-named-a-leader-in-quocirca-s-2026-act-print-industry-ecosystem-leadership-report</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T13:05:57+00:00</news:publication_date>
        <news:title>Pharos Named a Leader in Quocirca’s 2026 ACT Print Industry Ecosystem Leadership Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861345-quocirca-act-leader-badge-1200x1200.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190921-liminatus-pharma-announces-nasdaq-delisting-notification</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T00:28:26+00:00</news:publication_date>
        <news:title>Liminatus Pharma Announces Nasdaq Delisting Notification</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9ad52a99-f6dd-4ecb-8aa0-15713a0e8788/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190534-taimed-biologics-completes-phase-2b-enrollment-for-tmb-365-380-in-hiv-maintenance-therapy-study</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T00:00:00+00:00</news:publication_date>
        <news:title>TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1cb82885-f089-49cf-9399-8f9e4bc0918c/small/taimed-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190684-opch-investor-alert-kirby-mcinerney-llp-investigates-potential-claims-involving-option-care-health-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T00:00:00+00:00</news:publication_date>
        <news:title>OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190744-z-investor-alert-kirby-mcinerney-llp-investigates-potential-claims-involving-zillow-group-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T00:00:00+00:00</news:publication_date>
        <news:title>Z INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Zillow Group, Inc.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190829-hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T00:00:00+00:00</news:publication_date>
        <news:title>HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/085957ad-3bec-49ee-b13e-39961b83c7be/small/hutchmed-small-spaced-1000x305-whitebgd-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190844-rocket-lab-awarded-90m-contract-to-build-geo-satellites-hosting-space-domain-awareness-payload-for-u-s-space-force</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T00:00:00+00:00</news:publication_date>
        <news:title>Rocket Lab Awarded $90M Contract to Build GEO Satellites Hosting Space Domain Awareness Payload for U.S. Space Force  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bdfd4074-557e-4b11-a124-5bcc0d33f28b/medium/rocket-lab-s-lightning-spacecraft-production-line.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190865-ascentage-pharma-releases-latest-clinical-data-from-multiple-trials-at-asco-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-22T00:00:00+00:00</news:publication_date>
        <news:title>Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914030244-rjf-pro-ltd-initiates-live-sec-based-prediction-phase-for-mega-os-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T11:37:38+00:00</news:publication_date>
        <news:title>RJF Pro Ltd Initiates Live SEC-Based Prediction Phase for Mega OS AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863323-rjf3-761x395.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914189954-rosen-skilled-investor-counsel-encourages-upstart-holdings-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T23:21:00+00:00</news:publication_date>
        <news:title>ROSEN, SKILLED INVESTOR COUNSEL, Encourages Upstart Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – UPST</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190397-robbins-llp-encourages-upst-investors-to-contact-the-firm-for-information-about-the-class-action-against-upstart-holdings-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T23:12:02+00:00</news:publication_date>
        <news:title>Robbins LLP Encourages UPST Investors to Contact the Firm for Information About the Class Action Against Upstart Holdings, Inc.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190254-cvlt-class-action-notice-robbins-llp-reminds-investors-of-the-lead-plaintiff-deadline-in-the-commvault-systems-inc-class-action-lawsuit</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T23:08:20+00:00</news:publication_date>
        <news:title>CVLT Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Commvault Systems, Inc. Class Action Lawsuit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190057-atec-investor-alert-kirby-mcinerney-llp-investigates-potential-claims-involving-alphatec-holdings-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T23:00:00+00:00</news:publication_date>
        <news:title>ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190110-gehc-investor-alert-kirby-mcinerney-llp-investigates-potential-claims-involving-ge-healthcare-technologies-inc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T23:00:00+00:00</news:publication_date>
        <news:title>GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914190138-poet-shareholder-alert-securities-fraud-lawsuit-filed-on-behalf-of-poet-technologies-inc-investors-contact-kirby-mcinerney-llp-by-june-29-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T23:00:00+00:00</news:publication_date>
        <news:title>POET SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of POET Technologies Inc. Investors - Contact Kirby McInerney LLP by June 29, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/192da1d1-643f-4eee-b850-dde5b9f2b00f/small/linkedin-logo-300x300-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914159810-audiencerate-riccardo-fabbri-wird-chief-technology-officer-die-ki-gesteuerte-phase-der-plattformen-f-r-kmu-und-medienagenturen-beginnt</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T22:44:07+00:00</news:publication_date>
        <news:title>Audiencerate: Riccardo Fabbri wird Chief Technology Officer. Die KI-gesteuerte Phase der Plattformen für KMU und Medienagenturen beginnt</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/YWI5MGNkY2UtYjEyOC00Y2UxLTliM2MtMDI1YTQ1NzA4ZjBkLTEzMjMzNjAtMjAyNi0wNS0yMS1kZQ==/tiny/Audiencerate-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914159849-audiencerate-riccardo-fabbri-rejoint-l-quipe-en-tant-que-directeur-technique-d-but-de-la-phase-pilot-e-par-l-ia-des-plateformes-pour-pme-et</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T22:44:07+00:00</news:publication_date>
        <news:title>Audiencerate : Riccardo Fabbri rejoint l’équipe en tant que directeur technique. Début de la phase pilotée par l’IA des plateformes pour PME et agences médias</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/YWI5MGNkY2UtYjEyOC00Y2UxLTliM2MtMDI1YTQ1NzA4ZjBkLTEzMjMzNjAtMjAyNi0wNS0yMS1mcg==/tiny/Audiencerate-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914023977-prolific-evolutions-celebrates-career-growth-through-multiple-management-expansions</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T10:33:09+00:00</news:publication_date>
        <news:title>Prolific Evolutions Celebrates Career Growth Through Multiple Management Expansions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863275-prolific-evolutions-career-gr-1320x1647.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163533-fennec-pharmaceuticals-announces-new-research-supporting-integration-and-use-of-pedmark-at-the-2026-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T22:01:27+00:00</news:publication_date>
        <news:title>Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161784-z-investor-news-if-you-have-suffered-losses-in-zillow-group-inc-nasdaq-z-zg-you-are-encouraged-to-contact-the-rosen-law-firm-about-your-rights</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T22:00:00+00:00</news:publication_date>
        <news:title>Z Investor News: If You Have Suffered Losses in Zillow Group, Inc. (NASDAQ: Z, ZG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163048-biogen-and-denali-therapeutics-provide-update-on-phase-2b-luma-study-of-biib122-dnl151-in-early-stage-parkinson-s-disease</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T22:00:00+00:00</news:publication_date>
        <news:title>Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163092-samba-tv-launches-project-gravity-an-independent-data-activation-platform-for-the-agentic-era</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T22:00:00+00:00</news:publication_date>
        <news:title>Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a74fa7-09fe-4ed7-8189-1587683af145/small/samba-tv-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163509-biogen-and-denali-therapeutics-provide-update-on-phase-2b-luma-study-of-biib122-dnl151-in-early-stage-parkinson-s-disease</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T22:00:00+00:00</news:publication_date>
        <news:title>Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/898f19a9-f6ef-4d5a-8a4f-27709b81609a/small/denali-green-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163052-perspective-therapeutics-to-present-data-from-all-clinical-programs-at-the-2026-asco-annual-meeting-including-findings-from-212pb-vmt01-in-melanoma</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:51:13+00:00</news:publication_date>
        <news:title>Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e8b42463-3d31-441e-8c09-6b88826fe1c6/small/persp-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162936-zentalis-pharmaceuticals-to-present-phase-1b-muir-trial-data-showing-encouraging-clinical-activity-and-manageable-safety-profile-of-azenosertib-plus</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:39:11+00:00</news:publication_date>
        <news:title>Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ecb98bea-7a9f-4319-874c-1911777a5a46/small/zentalis-logo-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163237-smci-deadline-rosen-trusted-investor-counsel-encourages-super-micro-computer-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:34:02+00:00</news:publication_date>
        <news:title>SMCI DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Super Micro Computer, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 26 Deadline in Securities Class Action - SMCI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162553-crescent-biopharma-announces-trial-in-progress-presentation-for-ascend-study-of-cr-001-a-pd-1-x-vegf-bispecific-antibody-at-upcoming-american</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:30:00+00:00</news:publication_date>
        <news:title>Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163109-peace-acquisition-corp-announces-pricing-of-60-000-000-initial-public-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:30:00+00:00</news:publication_date>
        <news:title>Peace Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YTcwOTg0YjctZDMyOC00ODMwLTllZTYtMzMzMmNmZTdmZjYzLTUwMDE2Mjk5MC0yMDI2LTA1LTIxLWVu/tiny/Peace-Acquisition-Corp-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914163191-pliant-therapeutics-announces-upcoming-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:29:30+00:00</news:publication_date>
        <news:title>Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914160943-vci-global-received-nasdaq-notice-related-to-late-filing-of-20-f</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:25:00+00:00</news:publication_date>
        <news:title>VCI Global Received NASDAQ Notice Related to Late Filing of 20-F</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a5732b87-b5d4-4b9e-8452-fed90f097c33/small/vcig-logo-with-company-name-ticker-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162947-aktis-oncology-reports-first-in-human-clinical-imaging-and-dosimetry-data-for-aky-2519-demonstrating-robust-tumor-uptake-and-limited-normal-tissue</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:21:08+00:00</news:publication_date>
        <news:title>Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162799-commvault-investor-alert-bragar-eagel-squire-p-c-announces-that-a-class-action-lawsuit-has-been-filed-against-commvault-systems-inc-and</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:15:44+00:00</news:publication_date>
        <news:title>COMMVAULT INVESTOR ALERT: Bragar Eagel &amp; Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Commvault Systems, Inc. and Encourages Investors to Contact the Firm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162745-jupiter-neurosciences-announces-closing-of-2-0-million-registered-direct-offering</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:15:00+00:00</news:publication_date>
        <news:title>Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162796-sportradar-lawsuit-alert-bragar-eagel-squire-p-c-announces-that-a-class-action-lawsuit-has-been-filed-against-sportradar-group-ag-and-encourages</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:13:55+00:00</news:publication_date>
        <news:title>SPORTRADAR LAWSUIT ALERT: Bragar Eagel &amp; Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sportradar Group AG and Encourages Investors to Contact the Firm</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162747-black-diamond-therapeutics-announces-positive-phase-2-results-for-silevertinib-in-frontline-nsclc-patients-with-egfr-non-classical-mutations</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:13:52+00:00</news:publication_date>
        <news:title>Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914159935-autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:10:00+00:00</news:publication_date>
        <news:title>Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162258-whale-dynamic-joins-hitch-open-world-ai-championships-as-official-mapping-technology-partner-delivering-centimeter-accurate-hd-map-of-tianmen</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:06:06+00:00</news:publication_date>
        <news:title>Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NzVkNDgyNjEtODgxNy00ZTAxLTkyYWMtNjg2ZmVlYjE1ZTRiLTUwMDE2Mjk3Ni0yMDI2LTA1LTIxLWVu/tiny/Hitch-Interactive.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914159924-remix-therapeutics-announces-positive-data-from-phase-1-2-aria-study-of-first-in-class-myb-mrna-degrader-rem-422-in-patients-with-adenoid-cystic</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:05:00+00:00</news:publication_date>
        <news:title>Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4facea87-f600-4440-a295-a31bb083c9bd/small/remix-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162229-eikon-therapeutics-announces-availability-of-six-abstracts-for-presentation-at-the-2026-annual-meeting-of-the-american-society-of-clinical-oncology</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:05:00+00:00</news:publication_date>
        <news:title>Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/02bfb0a7-27fe-4be6-b2f9-bc6eaf27b1d9/small/eikon-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162615-moleculin-highlights-abstract-accepted-for-poster-presentation-at-the-2026-asco-annual-meeting-highlighting-cardiac-safety-data-for-annamycin</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:02:00+00:00</news:publication_date>
        <news:title>Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162250-lynozyfic-linvoseltamab-monotherapy-demonstrates-deep-and-rapid-responses-in-all-treated-patients-with-second-line-plus-systemic-amyloid-light</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:01:52+00:00</news:publication_date>
        <news:title>Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914160115-syndax-announces-four-revuforj-revumenib-abstracts-accepted-for-asco-2026-including-an-oral-presentation-of-post-transplant-data</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:01:00+00:00</news:publication_date>
        <news:title>Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161774-aldx-deadline-rosen-a-leading-law-firm-encourages-aldeyra-therapeutics-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:01:00+00:00</news:publication_date>
        <news:title>ALDX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161874-akari-therapeutics-reports-breakthrough-preclinical-data-demonstrating-synergistic-activity-of-aktx-101-with-kras-inhibition-in-kras-mutated</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:01:00+00:00</news:publication_date>
        <news:title>Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162647-aersale-announces-participation-at-the-2026-jefferies-aftermarket-mro-virtual-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:44+00:00</news:publication_date>
        <news:title>AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/60ccea51-2ced-477d-bf46-cd5517197ee2/small/aersale-logo-3c-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914159763-boehringer-ingelheim-s-oncology-portfolio-shows-strong-promise-across-multiple-cancers-at-asco-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026 </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914160133-legend-biotech-announces-presentations-at-asco-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Legend Biotech Announces Presentations at ASCO 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914160292-navient-declares-second-quarter-common-stock-dividend</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Navient declares second quarter common stock dividend</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bf6d2dc1-6f30-4b4b-a666-874f4a60663d/small/navient-r-logo2016-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914160307-cardiff-oncology-announces-webcast-to-discuss-updated-phase-2-crdf-004-data-for-onvansertib-in-first-line-ras-mutated-mcrc</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914160452-olema-oncology-announces-encouraging-initial-clinical-data-from-the-phase-1-study-of-op-3136-a-kat6-inhibitor-at-2026-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914160597-nvidia-announces-upcoming-events-for-financial-community</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>NVIDIA Announces Upcoming Events for Financial Community</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ad3b9553-6933-40b1-adfd-2ed199cd141c/small/nvidia-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161079-compass-therapeutics-to-present-promising-phase-1-clinical-data-for-ctx-8371-in-patients-with-advanced-malignancies-treated-in-the-post-checkpoint</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161304-ficerafusp-alfa-plus-pembrolizumab-demonstrated-differentiated-three-year-overall-survival-and-deep-responses-driven-by-tgf-inhibition-in-1l-r-m</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161429-immuneering-reports-17-3-months-median-overall-survival-in-first-line-metastatic-pancreatic-cancer-patients-treated-with-atebimetinib-plus</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161439-blossomhill-therapeutics-to-present-preliminary-results-from-phase-1-dose-escalation-backfill-cohorts-in-phase-1-2-solara-trial-of-omni-egfr</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/02f747e9-636d-467e-81f8-d942e9421158/small/blossomhill-vertical-fullcolor-cmyk1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161460-rgenta-therapeutics-presents-positive-preliminary-data-from-ongoing-phase-1a-b-clinical-trial-of-rgt-61159-in-patients-with-adenoid-cystic-carcinoma</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de2f6450-22c4-4c16-b785-04cea917de03/small/rgenta-logo-fullcolor-print-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161474-asher-biotherapeutics-announces-two-presentations-at-the-asco-2026-annual-meeting-highlighting-clinical-progress-across-its-cd8-targeted-cytokine</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3b2f30c8-cc67-45e5-a0d5-27b5e2c43de8/small/asher-bio-logo-rgb-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162207-hibercell-to-present-preliminary-results-from-the-phase-1b-trial-of-gcn2-activator-hc-7366-when-combined-with-welireg-belzutifan-for-the-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccRCC) at the Upcoming 2026 ASCO Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d168805a-8691-40f2-abcf-fb63a607f112/small/hybercell-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162215-trugolf-reports-first-quarter-2026-results</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T21:00:00+00:00</news:publication_date>
        <news:title>TruGolf Reports First Quarter 2026 Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/59645458-1a59-4898-b8e6-c6c599bcb64c/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162606-atrara-nasdaq-atra-deadline-may-22nd-bragar-eagel-squire-p-c-reminds-atara-biotherapeutics-inc-investors-they-have-until-may-22nd-to-seek</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:52:16+00:00</news:publication_date>
        <news:title>ATRARA (NASDAQ:ATRA) DEADLINE MAY 22nd: Bragar Eagel &amp; Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action Lawsuit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161769-cvb-financial-corp-names-george-a-borba-jr-chairman-of-the-board-prior-chairman-hal-w-oswalt-transitions-to-vice-chairman</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:45:00+00:00</news:publication_date>
        <news:title>CVB Financial Corp. Names George A. Borba Jr. Chairman of the Board; Prior Chairman Hal W. Oswalt Transitions to Vice Chairman</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a3d36b6d-b0e0-4c0a-b69c-ab3635da8eec/small/1947989-cvb-grey-logo-12-14-2020-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161939-amsc-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-may-27-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:45:00+00:00</news:publication_date>
        <news:title>AMSC to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 27, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e211940b-e356-45ff-b867-4d8c2353e215/small/unknown-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162143-rosen-skilled-investor-counsel-encourages-regencell-bioscience-holdings-limited-investors-to-secure-counsel-before-important-deadline-in-securities</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:43:57+00:00</news:publication_date>
        <news:title>ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162413-gossamer-deadline-rosen-leading-investor-counsel-encourages-gossamer-bio-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:39:25+00:00</news:publication_date>
        <news:title>GOSSAMER DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162080-seer-board-of-directors-unanimously-rejects-further-revised-unsolicited-proposal-from-radoff-jec-group</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:38:38+00:00</news:publication_date>
        <news:title>Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914162203-rosen-the-first-filing-firm-encourages-poet-technologies-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-first</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:35:20+00:00</news:publication_date>
        <news:title>ROSEN, THE FIRST FILING FIRM, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914161396-hub-group-declares-quarterly-dividend</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:35:00+00:00</news:publication_date>
        <news:title>Hub Group Declares Quarterly Dividend</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/983c3f27-320f-4c05-af5e-d5c57b8df0b3/small/hub-group-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914130530-hub-group-receives-expected-deficiency-notice-from-nasdaq-related-to-delayed-filing-of-quarterly-report-on-form-10-q</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:30:00+00:00</news:publication_date>
        <news:title>Hub Group Receives Expected Deficiency Notice from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/983c3f27-320f-4c05-af5e-d5c57b8df0b3/small/hub-group-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914131738-ofa-group-transitions-to-u-s-domestic-issuer-status-reaffirms-united-states-as-the-center-of-its-growth-strategy</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:28:00+00:00</news:publication_date>
        <news:title>OFA Group Transitions to U.S. Domestic Issuer Status; Reaffirms United States as the Center of Its Growth Strategy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e52a7458-e9a6-4327-988c-341d76730d12/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914131525-elwt-investor-news-if-you-have-suffered-losses-in-elauwit-connection-inc-nasdaq-elwt-you-are-encouraged-to-contact-the-rosen-law-firm-about</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:24:39+00:00</news:publication_date>
        <news:title>ELWT Investor News: If You Have Suffered Losses in Elauwit Connection, Inc. (NASDAQ: ELWT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914131634-adaptive-biotechnologies-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:17:30+00:00</news:publication_date>
        <news:title>Adaptive Biotechnologies to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128032-laureate-education-announces-election-of-julian-coulter-to-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:15:00+00:00</news:publication_date>
        <news:title>Laureate Education Announces Election of Julian Coulter to Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YTEwODlmY2YtNjcwZC00NzM2LWFmMGQtNzQ3NzczNTJkNDMxLTEwMjIyMDYtMjAyNi0wNS0yMS1lbg==/tiny/Laureate-Education-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128710-first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:15:00+00:00</news:publication_date>
        <news:title>First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7165e7cf-d98b-4a0f-90f3-3cd8f3a6b320/small/ftb-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914130491-x-energy-to-report-first-quarter-2026-results-on-june-4-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:15:00+00:00</news:publication_date>
        <news:title>X-energy to Report First Quarter 2026 Results on June 4, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDRhZGQwZGUtMGFhZC00MjM5LWEwNTQtNmVjMDhjMjYwYTM5LTEzMjEzNDktMjAyNi0wNS0yMS1lbg==/tiny/X-Energy-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914129302-chemung-financial-corporation-announces-quarterly-dividend</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:10:00+00:00</news:publication_date>
        <news:title>Chemung Financial Corporation Announces Quarterly Dividend</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4b16d4f9-3cc7-4aad-9de0-ee243c19ef0d/small/chemung-financial-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/913997025-executive-announces-formal-career-pivot-and-initiates-dispute-resolution-protocols-following-separation-from-dll</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T08:05:16+00:00</news:publication_date>
        <news:title>Executive Announces Formal Career Pivot and Initiates Dispute Resolution Protocols Following Separation from DLL</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863119-braheem-passe-1127x1395.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914127952-pacbio-to-participate-in-the-jefferies-global-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>PacBio to Participate in the Jefferies Global Healthcare Conference </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128442-zscaler-to-present-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>Zscaler to Present at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bc212637-6ad5-43b1-9aa5-f998c8fe68ba/small/zscaler-brandassets-logolockup-blue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128623-outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128685-hub-receives-expected-notification-of-deficiency-from-nasdaq-related-to-delayed-filing-of-annual-report-on-form-20-f-for-fiscal-year-2025</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>HUB Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F for Fiscal Year 2025</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6e976c16-ef4b-44bf-91c9-07ed7e45213b/small/horizontal-black-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128819-revolution-medicines-to-host-investor-conference-call-on-positive-rasolute-302-results-following-2026-asco-presentation</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128848-lpl-financial-reports-monthly-activity-for-april-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>LPL Financial Reports Monthly Activity for April 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53e1e8c9-85a6-4959-822d-a2cead7e0840/small/lpl-financial-logo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128898-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914128929-cavco-industries-reports-fiscal-2026-fourth-quarter-and-year-end-results</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>Cavco Industries Reports Fiscal 2026 Fourth Quarter and Year End Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/112d5a70-1623-4f0e-b69c-4812c90b35bc/small/cavco-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://techtimesnewyork.com/article/914129096-camp4-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Tech Times of New York</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T20:05:00+00:00</news:publication_date>
        <news:title>CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
